URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

Patrick John Finn net worth and biography

Patrick Finn Biography and Net Worth

Insider of Verona Pharma

Patrick John Finn Ph.D. serves as Chief Commercial Officer of the Company. He is our Senior Vice President of Commercial Operations from December 2018 to October 2019. Prior to joining us, Dr. Finn was Vice President of Sales at Enzymatics Inc., a developer, manufacturer, and marketer of enzymes for molecular biology applications, sold predominantly to manufacturers in research and diagnostic markets from January 2012 to March 2015. Dr. Finn holds a B.Sc. in Chemistry from Heriot-Watt University and a Ph.D. in Chemistry from the University of Southampton.

What is Patrick John Finn's net worth?: The estimated net worth of Patrick John Finn is at least $9.29 million as of November 11th, 2024. Mr. Finn owns 221,061 shares of Verona Pharma stock worth more than $9,288,983 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Finn may own. Learn More about Patrick John Finn's net worth.
How do I contact Patrick John Finn?: The corporate mailing address for Mr. Finn and other Verona Pharma executives is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. Verona Pharma can also be reached via phone at 011-44-0-2032834200 and via email at [email protected]. Learn More on Patrick John Finn's contact information.
Has Patrick John Finn been buying or selling shares of Verona Pharma?: Patrick John Finn has not been actively trading shares of Verona Pharma during the last ninety days. Learn More on Patrick John Finn's trading history.
Who are Verona Pharma's active insiders?: Verona Pharma's insider roster includes Lisa Deschamps (Director), David Ebsworth (Director), Martin Edwards (Director), Patrick Finn (Insider), Mark Hahn (CFO), Claire Poll (General Counsel), Kathleen Rickard (Insider), Anders Ullman (Director), and David Zaccardelli (CEO). Learn More on Verona Pharma's active insiders.
Are insiders buying or selling shares of Verona Pharma?: In the last year, Verona Pharma insiders bought shares 1 times. They purchased a total of 39,360 shares worth more than $188,928.00. In the last year, insiders at the sold shares 25 times. They sold a total of 2,130,680 shares worth more than $9,819,879.28. The most recent insider tranaction occured on December, 6th when CEO David Zaccardelli sold 162,800 shares worth more than $815,628.00. Insiders at Verona Pharma own 4.8% of the company. Learn More about insider trades at Verona Pharma.
Information on this page was last updated on 12/6/2024.

Patrick John Finn Insider Trading History at Verona Pharma

Patrick John Finn Buying and Selling Activity at Verona Pharma

Verona Pharma Company Overview

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $42.02

$40.10

$42.86

50 Day Range

MA: $37.72

$33.11

$42.68

2 Week Range

Now: $42.02

$11.39

$43.73

Volume

733,684 shs

Average Volume

934,459 shs

Market Capitalization

$3.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

>> Register for the Workshop Now